Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.755 USD | +0.86% | -1.14% | -47.75% |
Jun. 07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
Jun. 05 | Coherus BioSciences, Inc. Appoints Rita Karachun to Its Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.75% | 200M | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 23.64B | |
+1.69% | 22.39B | |
-11.72% | 17.78B | |
-41.74% | 16.43B | |
-13.47% | 16.34B | |
+2.23% | 13.56B | |
+27.13% | 11.59B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating